Evaluation of new anti-infective drugs for the treatment of disease caused by Mycobacterium kansasii and other mycobacteria. Infectious Diseases Society of America and the Food and Drug Administration.

Source:http://linkedlifedata.com/resource/pubmed/id/1477246

Download in:

View as

General Info

PMID
1477246